Polyrizon Ltd.(PLRZ)Earnings, Financials & Key Ratios
PLRZ•NASDAQ
$14.14
$59M mkt cap·28.3× P/E·Price updated May 7, 2026
AboutPolyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.Show more
- Revenue$0
- EBITDA-$1M-87.6%
- Net Income-$2M-157.5%
- EPS (Diluted)0.50+412.5%
- ROE-57.83%+94.5%
- ROIC-65.43%
- Interest Coverage-434.00-36.7%
PLRZ Key Insights
Polyrizon Ltd. (PLRZ) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 99 (top 1%)
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Shares diluted 47.3% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PLRZ Price & Volume
Polyrizon Ltd. (PLRZ) stock price & volume — 10-year historical chart
Loading chart...
PLRZ Growth Metrics
Polyrizon Ltd. (PLRZ) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM39.74%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-20.86%
Return on Capital
10 Years-3107.04%
5 Years-3107.04%
3 Years-581.39%
Last Year-48.74%
PLRZ Peer Comparison
Polyrizon Ltd. (PLRZ) competitors in Drug Delivery Technology Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SIGA | 338.88M | 4.73 | 14.33 | -31.8% | -43117.39% | -10.67% | 0.00 | |
 AGEN | 132.45M | 3.75 | -1102.94 | 10.37% | 0.1% | |||
 NVAX | 1.5B | 9.23 | 3.63 | 64.69% | -14.73% | |||
 NRXP | 84.71M | 3.06 | -2.28 | -157.28% | ||||
 PRPH | 4.98M | 0.12 | -0.05 | -84.75% | -38.72% | -6.08% | 3.34 | |
 NNOX | 115.07M | 1.76 | -1.93 | 13.91% | -452.82% | -35.55% | 0.04 | |
 PFE | 150.63B | 26.48 | 19.47 | -1.65% | 11.83% | 8.34% | 0.78 | |
 MRK | 277.34B | 112.29 | 15.42 | 1.18% | 28.12% | 36.14% | 0.96 |
Compare PLRZ vs Peers
Polyrizon Ltd. (PLRZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PLRZ Income Statement
Polyrizon Ltd. (PLRZ) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - |
| Cost of Goods Sold | 1K | 6K | 5K | 4K | 118K | 306K |
| COGS % of Revenue | - | - | - | - | - | - |
| Gross Profit | -1K▲ 0% | -6K▼ 500.0% | -5K▲ 16.7% | -4K▲ 20.0% | -118K▼ 2850.0% | -306K▲ 0% |
| Gross Margin % | - | - | - | - | - | - |
| Gross Profit Growth % | - | -500% | 16.67% | 20% | -2850% | - |
| Operating Expenses | 71K | 697K | 895K | 635K | 1.3M | 835.04K |
| OpEx % of Revenue | - | - | - | - | - | - |
| Selling, General & Admin | 33K | 452K | 548K | 303K | 768K | 442.99K |
| SG&A % of Revenue | - | - | - | - | - | - |
| Research & Development | 38K | 245K | 347K | 332K | 534K | 397.98K |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -5.92K |
| Operating Income | -72K▲ 0% | -703K▼ 876.4% | -895K▼ 27.3% | -635K▲ 29.1% | -1.3M▼ 105.0% | 3.44K▲ 0% |
| Operating Margin % | - | - | - | - | - | - |
| Operating Income Growth % | - | -876.39% | -27.31% | 29.05% | -105.04% | - |
| EBITDA | -71K | -697K | -890K | -631K | -1.18M | 120.69K |
| EBITDA Margin % | - | - | - | - | - | - |
| EBITDA Growth % | - | -881.69% | -27.69% | 29.1% | -87.64% | 109.87% |
| D&A (Non-Cash Add-back) | 1K | 6K | 5K | 4K | 118K | 117.25K |
| EBIT | -73K | -709K | -777K | -635K | -1.54M | -957.96K |
| Net Interest Income | 0 | -2K | -2K | -230K | -28K | -3.04M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 100K |
| Interest Expense | 0 | 2K | 2K | 2K | 3K | 3.14M |
| Other Income/Expense | -1K | -8K | 116K | 35K | -243K | -4.57K |
| Pretax Income | -73K▲ 0% | -711K▼ 874.0% | -779K▼ 9.6% | -600K▲ 23.0% | -1.54M▼ 157.5% | -1.14K▲ 0% |
| Pretax Margin % | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -73K▲ 0% | -711K▼ 874.0% | -779K▼ 9.6% | -600K▲ 23.0% | -1.54M▼ 157.5% | -957.66K▲ 0% |
| Net Margin % | - | - | - | - | - | - |
| Net Income Growth % | - | -873.97% | -9.56% | 22.98% | -157.5% | 39.74% |
| Net Income (Continuing) | -73K | -711K | -779K | -600K | -1.54M | -957.66K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02▲ 0% | -0.17▼ 877.0% | -0.20▼ 17.6% | -0.16▲ 20.0% | 0.50▲ 412.5% | -663.66▲ 0% |
| EPS Growth % | - | -877.01% | -17.65% | 20% | 412.5% | -20.86% |
| EPS (Basic) | -0.02 | -0.17 | -0.20 | -0.16 | 0.50 | - |
| Diluted Shares Outstanding | 4.19M | 4.19M | 1.31M | 2.03M | 2.99M | 1.44K |
| Basic Shares Outstanding | 4.19M | 4.19M | 1.31M | 2.03M | 2.99M | 1.44K |
| Dividend Payout Ratio | - | - | - | - | - | - |
PLRZ Balance Sheet
Polyrizon Ltd. (PLRZ) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Total Current Assets | 19K | 544K | 51K | 54K | 2.65M | 16.03M |
| Cash & Short-Term Investments | 10K | 523K | 36K | 41K | 2.55M | 15.83M |
| Cash Only | 10K | 523K | 36K | 4K | 2.55M | 15.83M |
| Short-Term Investments | 0 | 0 | 0 | 37K | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 9K | 21K | 15K | 13K | 99K | 204K |
| Total Non-Current Assets | 5K | 143K | 495K | 505K | 2.89M | 2.71M |
| Property, Plant & Equipment | 5K | 18K | 16K | 12K | 10K | 10K |
| Fixed Asset Turnover | - | - | - | - | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 2.88M | 2.7M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 125K | 479K | 493K | 0 | 0 |
| Total Assets | 24K▲ 0% | 687K▲ 2762.5% | 546K▼ 20.5% | 559K▲ 2.4% | 5.55M▲ 892.3% | 18.74M▲ 0% |
| Asset Turnover | - | - | - | - | - | 0.00x |
| Asset Growth % | - | 2762.5% | -20.52% | 2.38% | 892.31% | 7087.87% |
| Total Current Liabilities | 8K | 690K | 1.2M | 502K | 261K | 364K |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 200K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 672K | 1.16M | 263K | 45K | 319K |
| Current Ratio | 2.38x | 0.79x | 0.04x | 0.11x | 10.16x | 10.16x |
| Quick Ratio | 2.38x | 0.79x | 0.04x | 0.11x | 10.16x | 10.16x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 248K | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 248K | 0 | 0 |
| Total Liabilities | 8K | 690K | 1.2M | 750K | 261K | 364K |
| Total Debt | 0 | 0 | 0 | 200K | 0 | 0 |
| Net Debt | -10K | -523K | -36K | 196K | -2.55M | -15.83M |
| Debt / Equity | - | - | - | 3.51x | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | 0.00x |
| Net Debt / EBITDA | - | - | - | - | - | -131.15x |
| Interest Coverage | - | -351.50x | -447.50x | -317.50x | -434.00x | -0.30x |
| Total Equity | 16K▲ 0% | -3K▼ 118.8% | -652K▼ 21633.3% | 57K▲ 108.7% | 5.29M▲ 9173.7% | 18.38M▲ 0% |
| Equity Growth % | - | -118.75% | -21633.33% | 108.74% | 9173.68% | 25527.74% |
| Book Value per Share | 0.00 | -0.00 | -0.50 | 0.03 | 1.77 | 12733.89 |
| Total Shareholders' Equity | 16K | -3K | -652K | 57K | 5.29M | 18.38M |
| Common Stock | 49K | 326K | 0 | 0 | 0 | 0 |
| Retained Earnings | -1.43M | -2.14M | -2.92M | -3.52M | -5.07M | -5.24M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | -196K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
PLRZ Cash Flow Statement
Polyrizon Ltd. (PLRZ) cash flow — operating, investing & free cash flow history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Cash from Operations | -73K | -492K | -1.13M | -537K | -1.15M | -1.15M |
| Operating CF Margin % | - | - | - | - | - | - |
| Operating CF Growth % | - | -573.97% | -130.08% | 52.56% | -113.59% | -1181.7% |
| Net Income | -73K | -711K | -779K | -600K | -1.54M | -957.66K |
| Depreciation & Amortization | 1K | 6K | 5K | 4K | 118K | 117.25K |
| Stock-Based Compensation | 0 | 184K | 130K | 100K | 51K | 8 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | -144K | -48K | 250K | -1.8M |
| Working Capital Changes | -1K | 29K | -344K | 7K | -21K | 7.93K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -6K | -19K | -3K | 0 | 29K | 27.02K |
| Capital Expenditures | -6K | -19K | -3K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -1.98K |
| Cash from Financing | 89K | 1.02M | 648K | 505K | 3.67M | 18.42M |
| Debt Issued (Net) | 0 | 0 | 648K | 249K | -6K | -157K |
| Equity Issued (Net) | 89K | 1000K | 648K | 256K | 1000K | 2M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -648K | 0 | 0 | 9.21K |
| Net Change in Cash | 10K▲ 0% | 513K▲ 5030.0% | -487K▼ 194.9% | -32K▲ 93.4% | 2.55M▲ 8068.8% | 15.8M▲ 0% |
| Free Cash Flow | -79K▲ 0% | -511K▼ 546.8% | -1.14M▼ 122.1% | -537K▲ 52.7% | -1.15M▼ 113.6% | -812.23K▲ 0% |
| FCF Margin % | - | - | - | - | - | - |
| FCF Growth % | - | -546.84% | -122.11% | 52.69% | -113.59% | 38.52% |
| FCF per Share | -0.02 | -0.12 | -0.87 | -0.26 | -0.38 | -0.38 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.69x | 1.45x | 0.90x | 0.74x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
PLRZ Key Ratios
Polyrizon Ltd. (PLRZ) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -10938.46% | - | -1052.63% | -57.83% | -5.21% |
| Return on Invested Capital (ROIC) | - | - | - | -65.43% | -65.43% |
| Debt / Equity | - | - | 3.51x | - | 0.00x |
| Interest Coverage | -351.50x | -447.50x | -317.50x | -434.00x | -0.30x |
| FCF Conversion | 0.69x | 1.45x | 0.90x | 0.74x | 0.85x |
PLRZ Frequently Asked Questions
Polyrizon Ltd. (PLRZ) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Polyrizon Ltd. (PLRZ) grew revenue by 0.0% over the past year. Growth has been modest.
Polyrizon Ltd. (PLRZ) reported a net loss of $1.0M for fiscal year 2024.
Dividend & Returns
Polyrizon Ltd. (PLRZ) has a return on equity (ROE) of -57.8%. Negative ROE indicates the company is unprofitable.
Polyrizon Ltd. (PLRZ) had negative free cash flow of $0.8M in fiscal year 2024, likely due to heavy capital investments.
Explore More PLRZ
Polyrizon Ltd. (PLRZ) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates